Shu‐Cheng Chen

2.5k total citations · 1 hit paper
37 papers, 1.6k citations indexed

About

Shu‐Cheng Chen is a scholar working on Nephrology, Epidemiology and Molecular Biology. According to data from OpenAlex, Shu‐Cheng Chen has authored 37 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Nephrology, 9 papers in Epidemiology and 7 papers in Molecular Biology. Recurrent topics in Shu‐Cheng Chen's work include Dialysis and Renal Disease Management (11 papers), Chronic Kidney Disease and Diabetes (9 papers) and Chemokine receptors and signaling (6 papers). Shu‐Cheng Chen is often cited by papers focused on Dialysis and Renal Disease Management (11 papers), Chronic Kidney Disease and Diabetes (9 papers) and Chemokine receptors and signaling (6 papers). Shu‐Cheng Chen collaborates with scholars based in United States, United Kingdom and China. Shu‐Cheng Chen's co-authors include Allan J. Collins, Robert N. Foley, David T. Gilbertson, Suying Li, Peter A. McCullough, Sérgio A. Lira, George L. Bakris, Adam Whaley‐Connell, Tricia Roberts and Maria Wiekowski and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Immunology and PLoS ONE.

In The Last Decade

Shu‐Cheng Chen

36 papers receiving 1.5k citations

Hit Papers

United States Renal Data ... 2015 2026 2018 2022 2015 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shu‐Cheng Chen United States 20 605 255 245 242 210 37 1.6k
Sean Robbins United States 16 466 0.8× 428 1.7× 290 1.2× 197 0.8× 192 0.9× 23 2.0k
Cheng‐Hsu Chen Taiwan 23 592 1.0× 384 1.5× 95 0.4× 293 1.2× 474 2.3× 177 2.3k
Yaping Zhang China 15 542 0.9× 180 0.7× 210 0.9× 94 0.4× 93 0.4× 56 1.2k
Martin Busch Germany 22 686 1.1× 194 0.8× 321 1.3× 216 0.9× 220 1.0× 92 2.0k
Şule Şengül Türkiye 20 271 0.4× 255 1.0× 188 0.8× 115 0.5× 172 0.8× 93 1.2k
Benaya Rozen‐Zvi Israel 20 522 0.9× 198 0.8× 118 0.5× 74 0.3× 287 1.4× 81 2.1k
G. Offermann Germany 26 437 0.7× 273 1.1× 144 0.6× 112 0.5× 376 1.8× 134 1.9k
Kuo‐Hsiung Shu Taiwan 21 296 0.5× 200 0.8× 120 0.5× 85 0.4× 268 1.3× 75 1.3k
Joachim Misselwitz Germany 27 619 1.0× 159 0.6× 93 0.4× 332 1.4× 253 1.2× 51 2.4k
Jonathan Erlich Australia 24 258 0.4× 161 0.6× 278 1.1× 352 1.5× 174 0.8× 49 1.8k

Countries citing papers authored by Shu‐Cheng Chen

Since Specialization
Citations

This map shows the geographic impact of Shu‐Cheng Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu‐Cheng Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu‐Cheng Chen more than expected).

Fields of papers citing papers by Shu‐Cheng Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu‐Cheng Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu‐Cheng Chen. The network helps show where Shu‐Cheng Chen may publish in the future.

Co-authorship network of co-authors of Shu‐Cheng Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Shu‐Cheng Chen. A scholar is included among the top collaborators of Shu‐Cheng Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu‐Cheng Chen. Shu‐Cheng Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Deng, Hong, et al.. (2023). Ribavirin inhibits peste des petits ruminants virus proliferation in vitro. Veterinární Medicína. 68(12). 464–476. 1 indexed citations
3.
Chen, Shu‐Cheng, et al.. (2021). Autophagy inhibitor potentiates the antitumor efficacy of apatinib in uterine sarcoma by stimulating PI3K/Akt/mTOR pathway. Cancer Chemotherapy and Pharmacology. 88(2). 323–334. 14 indexed citations
4.
Chen, Shu‐Cheng, et al.. (2020). Insights into the unique characteristics of hepatitis C virus genotype 3 revealed by development of a robust sub-genomic DBN3a replicon. Journal of General Virology. 101(11). 1182–1190. 5 indexed citations
5.
Campos, Guilherme Rodrigues Fernandes, Shu‐Cheng Chen, Cíntia Bittar, et al.. (2020). A novel substitution in NS5A enhances the resistance of hepatitis C virus genotype 3 to daclatasvir. Journal of General Virology. 102(1). 5 indexed citations
6.
Memon, Imran, Keith C. Norris, Andrew S. Bomback, et al.. (2013). The Association between Parathyroid Hormone Levels and Hemoglobin in Diabetic and Nondiabetic Participants in the National Kidney Foundationʼs Kidney Early Evaluation Program. Cardiorenal Medicine. 3(2). 120–127. 7 indexed citations
7.
Mohan, Sumit, Edwin D. Huff, Jay B. Wish, et al.. (2013). Recovery of Renal Function among ESRD Patients in the US Medicare Program. PLoS ONE. 8(12). e83447–e83447. 31 indexed citations
8.
Whaley‐Connell, Adam, Joseph A. Vassalotti, Allan J. Collins, Shu‐Cheng Chen, & Peter A. McCullough. (2012). National Kidney Foundation's Kidney Early Evaluation Program (KEEP) Annual Data Report 2011: Executive Summary. American Journal of Kidney Diseases. 59(3). S1–S4. 9 indexed citations
9.
McCullough, Peter A., Joseph A. Vassalotti, Allan J. Collins, et al.. (2011). National Kidney Foundation's Kidney Early Evaluation Program (KEEP) Annual Data Report 2010: Executive Summary. American Journal of Kidney Diseases. 57(3). S1–S3. 9 indexed citations
10.
Stanton, Michaela C., Shu‐Cheng Chen, James V. Jackson, et al.. (2011). Inflammatory Signals shift from adipose to liver during high fat feeding and influence the development of steatohepatitis in mice. Journal of Inflammation. 8(1). 8–8. 113 indexed citations
11.
McCullough, Peter A., Joseph A. Vassalotti, Allan J. Collins, Shu‐Cheng Chen, & George L. Bakris. (2010). National Kidney Foundation's Kidney Early Evaluation Program (KEEP) Annual Data Report 2009: Executive Summary. American Journal of Kidney Diseases. 55(3). S1–S3. 44 indexed citations
12.
Whaley‐Connell, Adam, James R. Sowers, Peter A. McCullough, et al.. (2009). Diabetes Mellitus and CKD Awareness: The Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES). American Journal of Kidney Diseases. 53(4). S11–S21. 83 indexed citations
13.
Kang, Shan, Na Wang, Rong‐Miao Zhou, et al.. (2008). Polymorphisms in the matrix metalloproteinase‐2 and tissue inhibitor of metalloproteinase‐2 and the risk of human adenomyosis. Environmental and Molecular Mutagenesis. 49(3). 226–231. 24 indexed citations
14.
Martin, Andrea P., Elizabeth C. Coronel, Gen‐ichiro Sano, et al.. (2004). A Novel Model for Lymphocytic Infiltration of the Thyroid Gland Generated by Transgenic Expression of the CC Chemokine CCL21. The Journal of Immunology. 173(8). 4791–4798. 73 indexed citations
15.
Chen, Shu‐Cheng, Michael W. Leach, Yuetian Chen, et al.. (2002). Central Nervous System Inflammation and Neurological Disease in Transgenic Mice Expressing the CC Chemokine CCL21 in Oligodendrocytes. The Journal of Immunology. 168(3). 1009–1017. 48 indexed citations
16.
Collins, Allan J., et al.. (2002). United States Renal Data System assessment of the impact of the National Kidney Foundation-Dialysis Outcomes Quality Initiative guidelines. American Journal of Kidney Diseases. 39(4). 784–795. 74 indexed citations
17.
Chen, Shu‐Cheng, Borna Mehrad, Jane C. Deng, et al.. (2001). Impaired Pulmonary Host Defense in Mice Lacking Expression of the CXC Chemokine Lungkine. The Journal of Immunology. 166(5). 3362–3368. 63 indexed citations
18.
Holst, Peter Johannes, Mette M. Rosenkilde, Denise Manfra, et al.. (2001). Tumorigenesis induced by the HHV8-encoded chemokine receptor requires ligand modulation of high constitutive activity. Journal of Clinical Investigation. 108(12). 1789–1796. 10 indexed citations
19.
Holst, Peter Johannes, Mette M. Rosenkilde, Denise Manfra, et al.. (2001). Tumorigenesis induced by the HHV8-encoded chemokine receptor requires ligand modulation of high constitutive activity. Journal of Clinical Investigation. 108(12). 1789–1796. 86 indexed citations
20.
Bone‐Larson, Cynthia L., Kenneth J. Simpson, Lisa M. Colletti, et al.. (2000). The role of chemokines in the immunopathology of the liver. Immunological Reviews. 177(1). 8–20. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026